Sanofi, GSK to make available 200 million doses of the experimental COVID vaccine to COVAX ...United Arab Emirates

Gulf News - News
Sanofi, GSK to make available 200 million doses of the experimental COVID vaccine to COVAX
Sanofi and GlaxoSmithKline Plc said they've agreed to make available 200 million doses of the experimental COVID vaccine they're jointly developing to Covax, a global effort to provide shots for developing nations. The drugmakers signed the supply arrangement with Gavi, the Vaccine Alliance, according to a statement. Gavi is among the groups working with the World Health Organization (WHO) to ensure access to immunisation for people around the world. The US and other wealthy nations have been buying up most of the shots expected to be developed and tested early. Sanofi's shot, boosted by an adjuvant from Glaxo, is in early-stage human testing with results anticipated in December. The start

Read More Details
Finally We wish PressBee provided you with enough information of ( Sanofi, GSK to make available 200 million doses of the experimental COVID vaccine to COVAX )

Also on site :